JORGENSEN NATHAN D. (Chief Financial Officer) sold 3.0% of their position (4.67K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001104659-26-020179
Officer· Chief Financial Officer
Since Feb 2026
-4.67K
Net shares
Net seller
$17.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.67K
Price / share
$3.77
Trade value
$17.60K
% of position
3.0%
2/24/2026
156.08K→151.42K
Total
Net shares
−4.67K
Net value
-$17.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −4.67K | $3.77 | $17.60K | 3.0% | 156.08K | 151.42K |
| Total | −4.67K | -$17.60K | ||||||
Derivative Transactions0
No derivative transactions reported